Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
MGC Pharmaceuticals - Perth, Australia-based medicinal cannabis company - Appoints Yifat Steuer as the company's new chief operating officer and deputy chief executive officer. Steuer has worked across a range of pharmaceutical companies, including Johnson & Johnson, GSK PLC as well as with start-ups. The company said that Brett Mitchell has moved from executive chair to non-executive chair ‘to be more in line with corporate structuring of UK listed companies.’
MGC also appointed Hannam & Partners as financial and corporate advisers. Says Hannam & Partners is a ‘highly regarded’ UK advisory firm with a track record in UK capital markets, and more recently in the UK and EU cannabis sector.
Current stock price: 0.85 pence, up 6.3% on Tuesday
12-month change: down 72%
Copyright 2022 Alliance News Limited. All Rights Reserved.